INFORMATION RESOURCES

Essential Reading List

Autosomal Dominant Polycystic Kidney Disease
Jared J. Grantham, M.D.
NEJM 359; (14) 1477-1485 - October 2, 2008

Volume Progression in Polycystic Kidney Disease
Jared J. Grantham, M.D., Vicente E. Torres, M.D., Arlene B. Chapman, M.D., Lisa M. Guay-Woodford, M.D., Kyongtae T. Bae, M.D., Ph.D., Bernard F. King, Jr., M.D., Louis H. Wetzel, M.D., Deborah A. Baumgarten, M.D., Phillip J. Kenney, M.D., Peter C. Harris, Ph.D., Saulo Klahr, M.D., William M. Bennett, M.D., Gladys N. Hirschman, M.D., Catherine M. Meyers, M.D., Xiaoling Zhang, M.S., Fang Zhu, M.D., and John P. Miller, A.B., for the CRISP Investigators
NEJM 354; (20) 2122-2130 - May 18, 2006

Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
Robert W. Schrier, M.D., Kaleab Z. Abebe, Ph.D., Ronald D. Perrone, M.D., Vicente E. Torres, M.D., Ph.D., William E. Braun, M.D., Theodore I. Steinman, M.D., Franz T. Winklhofer, M.D., Godela Brosnahan, M.D., Peter G. Czarnecki, M.D., Marie C. Hogan, M.D., Ph.D., Dana C. Miskulin, M.D., Frederic F. Rahbari-Oskoui, M.D., Jared J. Grantham, M.D., Peter C. Harris, Ph.D., Michael F. Flessner, M.D., Ph.D., Kyongtae T. Bae, M.D., Charity G. Moore, Ph.D., M.S.P.H., and Arlene B. Chapman, M.D., for the HALT-PKD Trial Investigators
NEJM 371; (24) 2255-2266 - December 11, 2014

Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, M.D., Ph.D., Kaleab Z. Abebe, Ph.D., Arlene B. Chapman, M.D., Robert W. Schrier, M.D., William E. Braun, M.D., Theodore I. Steinman, M.D., Franz T. Winklhofer, M.D., Godela Brosnahan, M.D., Peter G. Czarnecki, M.D., Marie C. Hogan, M.D., Ph.D., Dana C. Miskulin, M.D., Frederic F. Rahbari-Oskoui, M.D., Jared J. Grantham, M.D., Peter C. Harris, Ph.D., Michael F. Flessner, M.D., Ph.D., Charity G. Moore, Ph.D., M.S.P.H., and Ronald D. Perrone, M.D., for the HALT-PKD Trial Investigators
NEJM 371; (24) 2267-2276 - December 11, 2014

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, M.D., Ph.D., Arlene B. Chapman, M.D., Olivier Devuyst, M.D., Ph.D., Ron T. Gansevoort, M.D., Ph.D., Jared J. Grantham, M.D., Eiji Higashihara, M.D., Ph.D., Ronald D. Perrone, M.D., Holly B. Krasa, M.S., John Ouyang, Ph.D., and Frank S. Czerwiec, M.D., Ph.D., for the TEMPO 3:4 Trial Investigators
NEJM 367; (25) 2407-2418 - December 20, 2012

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz, M.D., Klemens Budde, M.D., Marwan Mannaa, M.D., Jens Nürnberger, M.D., Christoph Wanner, M.D., Claudia Sommerer, M.D., Ulrich Kunzendorf, M.D., Bernhard Banas, M.D., Walter H. Hörl, M.D., Ph.D., Nicholas Obermüller, M.D., Wolfgang Arns, M.D., Hermann Pavenstädt, M.D., Jens Gaedeke, M.D., Martin Büchert, Ph.D., Christoph May, Ph.D., Harald Gschaidmeier, Ph.D., Stefan Kramer, Ph.D., and Kai-Uwe Eckardt, M.D.
NEJM 363; (9) 830-840 - August 26, 2010

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra, M.D., Diane Poster, M.D., Andreas D. Kistler, M.D., Fabienne Krauer, B.S., Shagun Raina, M.S., James Young, Ph.D., Katharina M. Rentsch, Ph.D., Katharina S. Spanaus, M.D., Oliver Senn, M.D., M.P.H., Paulus Kristanto, Ph.D., Hans Scheffel, M.D., Dominik Weishaupt, M.D., and Rudolf P. Wuthrich, M.D.
NEJM 363; (9) 820-829 - August 26, 2010

 

Additional Information Resources


PKD Foundation
pkdcure.org

American Kidney Fund
kidneyfund.org/kidney-disease/other-kidney-conditions/polycystic-kidney-disease.html

National Kidney Foundation
kidney.org

NORD (National Organization for Rare Diseases)
rarediseases.org

NIH Institute of Diabetes and Digestive and Kidney Diseases
niddk.nih.gov/health-information/kidney-disease

ARPKD/CHF Alliance
arpkdchf.org

American Association of Kidney Patients
aakp.org